Ajanta Pharma - Financial Results & Results Press Release for March 31, 2013
Link: Click Here
Ajanta Pharma - Press Release
Link: Click Here
Ajanta Pharma - Board recommends Dividend
Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 30, 2013, inter alia, have recommended Dividend @ Rs. 6.25 per equity share of the face value of Rs. 5/- each, subject to approval of Shareholders at the ensuing Annual General Meeting to be held on July 13, 2013.
Ajanta Pharma - Allotment of Shares under ESOS, 2011
Ajanta Pharma Ltd has informed BSE that the Compensation Committee of Directors at its meeting held on April 30, 2013, has allotted 16,800 fully paid up equity shares of Rs. 5/- each. These shares have been allotted upon exercising of options granted to the employees under Employees Stock Option Scheme - 2011 of the Company.
My Views:The results to me looks outstanding as I can see the revenue growth of 40% for 3rd consecutive quarter, which can be considered nothing less than an unbelievable performace by the company.
Hats Off to the management!!!!!!!
If one asks me, I would say long term investor are advised to stay invested (But, everyone can take their own decision)
I expect a target of 1000 by end of year. (If the growth story continues in similar fashion)
I wont be commenting on any short term movements... :-)
http://www.valuenotes.com/Quarterly-Analysis/Ajanta-Pharma-Impressive-improvement-in-margins/182090/12540406.00/C
ReplyDeletehttp://microcapintel.com/2013/05/02/ajanta-pharma-reports-improvement/
ReplyDeleteAnother promoter buying report from Ajanta Pharma even at price more than 800.....
ReplyDeleteIts practically unbelievable......
A day before, a notice was given that promoters pledged 3 Lakh shares....
As far as I think, that was just done, to get few more money to buy few more shares from open market....
They will look to complete 75% holding within 1-2 quarters....
Ajanta Pharma rallies on promoter stake buys
ReplyDeletehttp://www.business-standard.com/article/markets/ajanta-pharma-rallies-on-promoter-stake-buys-113050800287_1.html
Lots of people have asked me regarding what to do with Ajanta Pharma now?
ReplyDeleteWell thats a very tough question...
When I first suggested this stock, it was trading at 415 levels....
http://fundamentalstockideas.in/ajanta-pharma-rewriting-the-future-of-india-in-pharma-industry/
From that, it has appreciated around 120% which is not bad....
I gave a target of 800-1000 with time frame of about 2 years....
It has already reached those levels in 9 months only....
As we have seen recently, promoters have bought lots of shares from open market...around 815-900 levels..... which is impressive considering the future of the company...
As far as what I have learnt, Promoters never buy their own shares from open market...based on previous results....
Hence, as far as I understand, there is something that is going to happen in future, because of which they are buying aggressively at this price also.....
Those who bought with a target that I gave, can book profits if they want..... but as far as I am concerned.... I am planning to wait further.... as promoters are still buying...
One of the best option in these cases, that I have learnt from my brother is to book profit for the initial investment amount, and leave the rest as it is for life time....
For eg., If you invested in Ajanta shares worth Rs 10000 in Sept 12, as suggested here, that has been appreciated to Rs 22000 today...... so, selling shares worth 10000 Rs is not a bad option, and let your remaining shares worth 12000 Rs as it is, for life time.....
So, you have got your initial investment amount back, and let the profit multiply/divide in itself.... which should not bother you much.... :-)
Ajanta Pharma hits 1000 for the first time on both the exchanges..
ReplyDeleteCongratulations to all those who invested in this script....
Fixes Book Closure for Dividend & AGM:
ReplyDeleteAjanta Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 22, 2013 to July 26, 2013 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on July 26, 2013.
Further the Company has informed that the date of payment of dividend on equity shares would be on or after July 26, 2013, subject to approval of the shareholders at the forthcoming Annual General Meeting.
Change in Directorate:
Ajanta Pharma Ltd has informed BSE that Mr. Rajesh M. Agrawal and Mr. K H Viswanathan have been appointed as Additional Directors w.e.f. April 30, 2013.
Further, Mr. Rajesh M. Agrawal is appointed as Joint Managing Director effective from May 01, 2013 subject to the approval of shareholders at the ensuing Annual General Meeting.